REFERENCES
- Koda Y., Nishi S.-I., Suzuki M., Hirosawa Y. Lipoprotein(a) is a Predictor for Cardiovascular Mortality of Hemodialysis Patients. Kid. Int. 1999; 56(Suppl. 71)251–253
- Cressman M.D., Heyka R.J., Paganini E.P., O'Neil J., Skibiñski C.I., Hoff H.F. Lipoprotein(a) is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients. Circulation 1992; 86: 475–482
- Jungers P., Massy Z.A., Khoa T.N., Fumeron C., Labrunie M., Lacour B., Descamps-Latscha B., Man N.K. Incidence and Risk Factors of Atherosclerotic Cardiovascular Accidents in Predialysis Chronic Renal Failure Patients: a Perspective Study. Nephrol. Dial. Transplant 1997; 12: 2597–2602
- Thillert J., Faucher C., Issad B., Allouche M., Chapman J., Jacobs C. Lipoprotein(a) in Patients Treated by Continuous Ambulatory Peritoneal Dialysis. Am. J. Kidney Dis. 1993; 22: 226–232
- Kandoussi A.M., Cachera C., Paginez D., Dracon M., Fruchart J.C., Tacquet A. Plasma Level of Lipoprotein Lp(a) is High in Predialysis or Hemodialysis, but not in CAPD. Kidney Int. 1992; 42: 424–425
- Kostner K.M., Banyai S., Banyai M., Bodlaj G., Maurer G., Derfler K., Hörl W.H., Oberbauer R. Urinary apolipoprotein(a) excretion in patients with proteinuria. Ann. Med. 1998; 30: 497
- Bairaktari E., Elisaf M., Tsolas O., Siamopoulos K.C. Serum Lp(a) Levels in Patients with Moderate Renal Failure. Nephron 1998; 79: 367–368
- De-Lima J.J., Maranhao R.C., Latrilla M.C., Diament J., Romeo J.E., Krieger E.M., Pileggi F. Early Elevation of Lipoprotein(a) Levels in Chronic Renal Insufficiency. Renal Failure 1997; 19: 145–154
- Attman P.-O., Samuelsson O., Alaupovic P. Lipoprotein Metabolism and Renal Failure. Am. J. Kidney Dis. 1993; 21: 573–592
- Samuelsson O., Attman P.-O., Knight-Gibson C. Lipoprotein Abnormalities Without Hyperlipidaemia in Moderate Renal Insufficiency. Nephrol. Dial. Transplant 1994; 9: 1580–1585
- Kimak E., Solski J., Janicka L., Ksi¿ek A., Janicki K. Concentration of Lp(a) and Other Apolipoproteins in Predialysis, Hemodialysis, Chronic Ambulatory Peritoneal Dialysis and Post-transplant Patients. Clin. Chem. Lab. Med. 2000; 38: 421–425
- Attman P.-O., Samuelsson J.M., Johansson A.-C., Ljungman S., Weiss L.G., Knight-Gibson C., Alaupovic P. Apolipoprotein B-containing Lipoproteins in Renal Failure: The Relation to Mode of Dialysis. Kidney Int. 1999; 55: 1536–1542
- Kimak E., Solski J., Janicka L. Lipoprotein Profiles at Different Stages of Chronic Renal Insufficiency (CRI). Renal Failure 2000; 22: 63–71
- Shoji T., Nishiki Y., Kawagishi T., Kawasaki K., Taniwaki H. Intermediate-Density Lipoprotein as an Independent Risk Factor for Aortic Atherosclerosis in Hemodialysis Patients. J. Am. Soc. Nephrol. 1998; 9: 1277–1284
- Alaupovic P. Metabolic and Clinical Significance of Plasma Lipoprotein Families Defined by Apolipoprotein Composition. Anal. Acad. Nac. Cs Ex Fis y Nat; Buenos Aires: Argentina, 1998; 50: 89–106
- Stenvinkel P., Heimbürger O., Tuck C.H., Berglund L. Apo(a)-isoform Size, Nutritional Status and Inflammatory Markers in Chronic Renal Failure. Kidney Int. 1998; 53: 1336–1342
- Kimak E., Solski J. Lp(a) Concentration in Moderate Renal Insufficiency. Am. Clin. Lab. 2001; 20: 28–30